Strides Pharma to host Q2 FY26 earnings call

Strides Pharma Science Limited announced an earnings call to discuss its unaudited financial results for the quarter and half-year ended September 30, 2025. The call is scheduled for Friday, October 31, 2025, at 16:30 hrs IST.

The company's senior management, including managing director & group ceo Badree Komandur and group cfo Vikesh Kumar, will participate in the interaction, focusing on the Q2 FY26 performance.

Participants can join the call by pre-registering online or using various dial-in numbers provided for India, USA, UK, Singapore, and Hongkong. Further details and updates will be available on the company’s website, www.strides.com.